BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 16540747)

  • 1. Quantifying the health benefits of genetic tests: a clinical perspective.
    Scheuner MT; Rotter JI
    Genet Med; 2006 Mar; 8(3):141-2. PubMed ID: 16540747
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantifying the health benefits of genetic tests: the importance of a population perspective.
    Khoury MJ; Jones K; Grosse SD
    Genet Med; 2006 Mar; 8(3):191-5. PubMed ID: 16540755
    [No Abstract]   [Full Text] [Related]  

  • 3. Questions linger over utility of genetic testing.
    Lavine G
    Am J Health Syst Pharm; 2008 May; 65(9):793-5. PubMed ID: 18436721
    [No Abstract]   [Full Text] [Related]  

  • 4. Concerns over 'shifting sands' linger as genetic testing expands.
    Khamsi R
    Nat Med; 2008 Jun; 14(6):589. PubMed ID: 18535560
    [No Abstract]   [Full Text] [Related]  

  • 5. Risks and benefits of population-based genetic testing for Mendelian subsets of common diseases were examined using the example of colorectal cancer risk.
    Madlensky L; McLaughlin JR; Carroll JC; Goel V; Frank JW
    J Clin Epidemiol; 2005 Sep; 58(9):934-41. PubMed ID: 16085197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A surveillance clinic for children and adolescents with, or at risk of, hereditary cancer predisposition syndromes.
    Leedman N; Princehorn M; Gottardo N; Franklin C; D'Souza R; Kiraly-Borri CE
    Med J Aust; 2021 Apr; 214(7):335-335.e1. PubMed ID: 33772786
    [No Abstract]   [Full Text] [Related]  

  • 7. Principles of population-based genetic screening and their importance.
    Drown DJ
    Prog Cardiovasc Nurs; 2003; 18(2):113-4. PubMed ID: 12732806
    [No Abstract]   [Full Text] [Related]  

  • 8. Does the addition of information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype?
    Dwyer T; Stankovich JM; Blizzard L; FitzGerald LM; Dickinson JL; Reilly A; Williamson J; Ashbolt R; Berwick M; Sale MM
    Am J Epidemiol; 2004 May; 159(9):826-33. PubMed ID: 15105175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reacting to genetic risk: an experimental survey of life between health and disease.
    Almeling R; Gadarian SK
    J Health Soc Behav; 2014 Dec; 55(4):482-503. PubMed ID: 25413807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public perceptions of presymptomatic testing for Alzheimer disease.
    Caselli RJ; Langbaum J; Marchant GE; Lindor RA; Hunt KS; Henslin BR; Dueck AC; Robert JS
    Mayo Clin Proc; 2014 Oct; 89(10):1389-96. PubMed ID: 25171823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethical issues concerning genetic testing and screening in public health.
    Hodge JG
    Am J Med Genet C Semin Med Genet; 2004 Feb; 125C(1):66-70. PubMed ID: 14755435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and public health implications of emerging genetic technologies.
    Laberge AM; Burke W
    Semin Nephrol; 2010 Mar; 30(2):185-94. PubMed ID: 20347647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Precision medicine meets public health: population screening for BRCA1 and BRCA2.
    Levy-Lahad E; Lahad A; King MC
    J Natl Cancer Inst; 2015 Jan; 107(1):420. PubMed ID: 25550384
    [No Abstract]   [Full Text] [Related]  

  • 14. Managing genetic tests, surveillance, and preventive medicine under a public health insurance system.
    Filipova-Neumann L; Hoy M
    J Health Econ; 2014 Mar; 34():31-41. PubMed ID: 24463140
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular genetic tests in advanced non-small cell lung cancer: practical relevance].
    Sebastian M; Niederle N; Thomas M; Reck M; Schmittel A; Fischer B; Overbeck T; Gröschel A; Deppermann M; Pirker R; Huber RM; Eberhardt W; Griesinger F
    Dtsch Med Wochenschr; 2014 Oct; 139(41):2096-100. PubMed ID: 25268213
    [No Abstract]   [Full Text] [Related]  

  • 16. Genetic epidemiology and public health: hope, hype, and future prospects.
    Davey Smith G; Ebrahim S; Lewis S; Hansell AL; Palmer LJ; Burton PR
    Lancet; 2005 Oct 22-28; 366(9495):1484-98. PubMed ID: 16243094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic information in the workplace. Implications for occupational health surveillance.
    Schill AL
    AAOHN J; 2000 Feb; 48(2):80-91. PubMed ID: 10865550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive genetic testing for complex diseases: a public health perspective.
    Marzuillo C; De Vito C; D'Andrea E; Rosso A; Villari P
    QJM; 2014 Feb; 107(2):93-7. PubMed ID: 24049051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of interest in evidence-based evaluations of genetic tests.
    Botkin JR; Teutsch SM; Kaye CI; Hayes M; Haddow JE; Bradley LA; Szegda K; Dotson WD;
    Genet Med; 2010 Apr; 12(4):228-35. PubMed ID: 20118789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Will genomics widen or help heal the schism between medicine and public health?
    Khoury MJ; Gwinn M; Burke W; Bowen S; Zimmern R
    Am J Prev Med; 2007 Oct; 33(4):310-7. PubMed ID: 17888858
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.